Declaring Illumina’s product architecture sturdy enough to support whatever the market demands, CEO Jay Flatley last week painted a sunny picture of the genotyping market at Leerink Swann’s Life Science Tools Roundtable Conference in New York.
Specifically, Flatley said that the firm’s assays and existing products are flexible enough to handle higher-density arrays should the market call for them, as well as some of the potential consumer genotyping services that Illumina is beginning to explore.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

National Geographic reports that marine mammals have lost a gene that could make them more susceptible to organophosphate damage.

NPR reports on Human Cell Atlas Consortium's effort to catalog all the different cell types within the human body.

The Union of Concerned Scientists surveyed US government scientists about Trump Administration policies and more, Science reports.

In PNAS this week: history and genetic diversity of the scarlet macaw, approach for predicting human flu virus evolution, and more.